Iris Technologies' digital screens help with concussion recovery
Northern Biologics Announces Exciting New CEO
Northern Biologics, the relatively young organization that specializes in intelligent immune-oncology products, acquired some impressive new leadership this past month. “Dr. Vickers is a preeminent R&D leader with more than two decades of experience in the biotech and pharmaceutical industry” Philip Vickers was announced as the new CEO on November 9th. Vickers joins Northern Biologics from the Executive Committee for Shire where he was the head of Research & Development.
Proposed PMPRB Regulations Published for Comment | Insights | Torys LLP
The Proposed Regulations essentially mirror the provisions of the PMPRB consultation paper published earlier in 2017 by introducing new factors the PMPRB may consider in determining the value of a medicine, removing the United States as a comparator country for pricing reference, and modifying reporting requirements so rebates and discounts to any third parties (e.g.